Results 151 to 160 of about 234,694 (355)

The assay of human plasminogen with casein as substrate [PDF]

, 1961
Moisés Derechin
openalex   +1 more source

IgG4‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets

Allergy, EarlyView.
ABSTRACT IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses.
Louisa Tedesco, Syed B. Ali, Baran Erman, Safa Baris, Harshita Pant, Pravin Hissaria, Yelda Bilginer, Damon J. Tumes, Gökhan Cildir   +8 more
wiley   +1 more source

Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study [PDF]

, 1969
Maria B. Bernik, Hau C. Kwaan
openalex   +1 more source

Continuity of care and risk of vision loss in patients with newly developed macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho, Minah Park, Dae Joong Ma, In Hwan Hong, Hyunkyu Kim, Seung Hoon Kim   +5 more
wiley   +1 more source

Improved Procedure for the Isolation of Human Plasminogen

, 1961
Daniel L. Kline, Jacob B. Fishman
openalex   +1 more source

Interventions for submacular haemorrhage: A systematic review and network meta‐analysis of controversies—On behalf of the Spanish Vitreo‐Retinal Society (SERV)

Acta Ophthalmologica, EarlyView.
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate, Pablo Redruello‐Guerrero, Laura de Juan Hernández, Gregorio Benites‐Narcizo, Mario Rivera‐Izquierdo, José García‐Arumí, José Carlos Pastor Jimeno   +6 more
wiley   +1 more source

Prevalence and impact of additional CHIP mutations in JAK2V617F‐positive ischaemic cerebrovascular patients

British Journal of Haematology, EarlyView.
Summary The JAK2V617F mutation is associated with increased cardiovascular risk, including ischaemic stroke. This study investigates the prevalence of additional mutations in ischaemic cerebrovascular patients with and without JAK2V617F to better understand the mechanisms contributing to thrombotic risk.
Marie Hvelplund Kristiansen, Vibe Skov, Morten Kranker Larsen, Lasse Kjær, Hans Carl Hasselbalch, Troels Wienecke   +5 more
wiley   +1 more source

The Active Site of Bovine Plasminogen Activator

, 1968
Louis Summaria, Chung‐Mei Ling, William R. Groskopf, Kenneth C. Robbins   +3 more
openalex   +1 more source

The activation of plasminogen by staphylokinase: comparison with streptokinase [PDF]

, 1960
Flora M. Davidson
openalex   +1 more source

The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system

Brain Pathology, EarlyView.
Sphingolipids are vital components of cell membranes. Metabolic disruptions of sphingolipids, including ceramide and sphingosine‐1‐phosphate, are linked to neurological disorders. This article summarizes the classification, structure, and metabolic processes of sphingolipids, and the physiological and pathological effects of sphingolipid metabolism and
Tian Li, Haoying He, Ejuan Zhang, Fengjiao Hu, Zhuo Wang, Jian Xu, Mengliu Zeng, Biwen Peng   +7 more
wiley   +1 more source